{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: These results show that the G2 - phase chromosomal radiosensitivity assay can be used for the detection of A - T heterozygotes .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| A-T |\n\nExplanation:\n\n* A-T is a disease entity mentioned in the paragraph as a heterozygote that can be detected using the G2 - phase chromosomal radiosensitivity assay.\n\nNote: A-T refers to Ataxia-Telangiectasia, a rare genetic disorder that affects the brain and nervous system, and is characterized by progressive cerebellar ataxia, oculocutaneous telangiectasia, and immunodeficiency."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| A-T |\n\nExplanation:\n\n* A-T is the only disease entity mentioned in the paragraph.\n* \"G2 - phase chromosomal radiosensitivity assay\" is not a disease entity, but rather a laboratory test used to detect genetic disorders.\n* \"heterozygotes\" is not a disease entity, but rather a term used to describe individuals who have two different alleles of a particular gene."}
  ]
}